Primary cutaneous plasmacytosis is an uncommon cutaneous disorder with multiple cutaneous nodules and plaques mainly on face and trunk. This entity is thought to be a reactive process with unknown etiology. Pulmonary involvement could be found as a part of systemic plasmacytosis whereas cutaneous plasmacytosis was also reported with other pulmonary disorders. This report presents the case of cutaneous plasmacytosis and the review of pulmonary findings reported in plasmacytosis.
Introduction
The primary cutaneous plasma cell disorders can range from malignant to benign plasma cell neoplasms. The malignant conditions are neoplastic diseases having monoclonal proliferations, rapid progression and fatal outcome while the benign plasma cell disorders usually show polyclonality, chronicity and benign process, including plasmacytosis. 1 Some authors stated that cutaneous and systemic plasmacytosis should be the same entity because systemic involvement has not been found in the former due to a lack of sufficient investigations. 2 In this report, the authors present a case of cutaneous plasmacytosis, which is a rare reactive skin condition and also a review pulmonary findings in this disease.
Case Report
A 41-year-old male presented with the history of persistent asymptomatic papules and plaques on face, neck and trunk which gradually increased over two years ( Figure 1 ). Physical examination revealed multiple discrete infiltrative erythematous to brownish plaques and nodules on face, neck, trunk and back. The skin biopsy showed superficial and deep perivascular and periadnexal infiltrations with mature plasma cells, admixed with some lymphocytes and histiocytes with no atypicality (Figure 2) . The immunohistochemistry revealed no light chain restriction.
Basic chemical laboratory testing was within normal limits. Serology for anti-human immunodeficiency virus, anti-nuclear antibody and syphilis were negative. Urine Bence Jones protein, b2-microglobulin, serum free light chain analysis and serum protein electrophoresis were all within normal limits. Bone marrow biopsy resulted in moderately hypercellularity with normal maturation. However, a speculated lung nodule with cavity 1.7 cm in diameter was seen at right upper lobe from chest X-ray. Three consecutive sputum examinations were negative for acid fast bacilli. With previous reports of pulmonary involvement in plasmacytosis, computer tomography (CT) scan of the chest was done and revealed a group of cavitary pulmonary nodules with nearby tree-in-bud pattern, suggestive of tuberculosis rather than malignancy. Finally, the diagnosis of pulmonary tuberculosis was confirmed by bronchoalveolar fluid culture and lung biopsy.
After successful course of 6-month antituberculosis regimen, there was a resolution of pulmonary lesions but skin lesions still progressed gradually. Intralesional steroid injection and tacrolimus ointment application were commenced but did not show promising results. Then, the patient decided to have a scheduled follow-up visits.
Primary cutaneous plasmacytosis or cutaneous plasmacytosis was thought to be a reactive process with unknown etiology and characterized by disseminated, asymptomatic reddish-brown macules, plaques and nodules mainly on upper trunk and face. Classification for cutaneous plasmacytosis was coined by Watanabe et al. in 1986. 1 Cutaneous plasmacytosis without pulmonary involvement by definition, had been reported with some abnormal pulmonary findings such as lung carcinoma and lung nodules. 2,3 A primary plasmacytosis affecting more than two organs was classified as systemic plasmacytosis. The common organ involvements were superficial lymphadenopathy (58%) and hepatosplenomegaly (28%), respectively. 4 Pulmonary findings of systemic and cutanoeus plasmacytosis were demonstrated as Table 1 . As far as the author's review, there were two cases which had pulmonary granuloma and plasmacytosis (case No. 4, 5).
Uhara et al. reviewed that the most characteristic histopathologic change of plasmacytosis was perivascular and periadnexal patchy infiltration of matured typical plasma cells with some lymphocytes and histiocytes. Immunohistochemistry was found to be polyclonal IgG-positive predominated. 4 Other important differential diagnosis includes syphilis, Lyme disease, systemic lupus erythematosus and plasmacytoma. 8 The extensive investigations of our patient showed no distinctive causes of plasma cell proliferation. Firstly, the authors believed that cutaneous plasmacytosis might be a reactive process of pulmonary tuberculosis. However, the skin lesions did not resolve after successful course of anti-tuberculosis drugs. As a result, pulmonary tuberculosis, which occurs com- monly in Thailand, was believed to be a coincidence rather than association with plasmacytosis. In vitro study had shown that three patients with cutaneous plasmacytosis had elevated plasma IL-6 levels which induced the final maturation of B cells into immunoglobulin-producing cells. IL-6 levels were subsequently decreased after steroid addition. 9 Tacrolimus application was reported to reduce erythema and induration. 10 Unfortunately, the patient did not show favorable outcome after three months of steroid injections and tacrolimus ointment, respectively.
Conclusions
In summary, the authors describe the rare case of cutaneous plasmacytosis which is diagnosed at the same time of pulmonary tuberculosis. Data from more patients are required in order to conclude that plasmacytosis is a reactive process or co-incidence of tuberculosis. However, lung is another organ that should be taken into consideration for sufficient investigation of plasmacytosis. 
